We are live on
!
Find out more
HP
Harbourvest Partners Portfolio holdings
AUM
$101M
1-Year Est. Return
38.13%
This Fund
S&P 500
This Quarter
Est. Return
+13.94%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$179M
AUM Growth
+$13.2M
(+8%)
Cap. Flow
-$6.7M
Cap. Flow
% of AUM
-3.75%
Top 10 Holdings %
Top 10 Hldgs %
98.02%
Holding
23
New
7
Increased
2
Reduced
5
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KA
Kineta, Inc. Common Stock
KA
|
+$5.81M |
| 2 |
Nutanix
NTNX
|
+$4.44M |
| 3 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$658K |
| 4 |
Senseonics Holdings Inc
SENS
|
+$634K |
| 5 |
Groupon
GRPN
|
+$525K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wayfair
W
|
+$11.9M |
| 2 |
Box
BOX
|
+$2.46M |
| 3 |
XLRN
Acceleron Pharma
XLRN
|
+$1.44M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$1.36M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$1.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 81.07% |
| 2 | Financials | 5.83% |
| 3 | Healthcare | 4.5% |
| 4 | Technology | 3.41% |
| 5 | Energy | 0.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Wayfair
W
$12.5B
| $144M | 80.58% |
3,558,191
-302,320
| -8% | -$11.9M |
|
|
HAPN
2
Happen Inc
HAPN
$2.19B
| $10.4M | 5.83% |
380,041
| – | – |
|
|
FNJN
3
DELISTED
Finjan Holdings, Inc.
FNJN
| $7.47M | 4.18% |
4,303,435
| – | – |
|
|
KA
4
DELISTED
Kineta, Inc. Common Stock
KA
| $3.45M | 1.93% |
+3,147
| New | +$5.81M |
|
|
5
Nutanix
NTNX
$16B
| $3.1M | 1.74% |
+165,356
| New | +$4.44M |
|
|
6
Box
BOX
$4.36B
| $1.97M | 1.1% |
120,805
-145,594
| -55% | -$2.46M |
|
|
XLRN
7
DELISTED
Acceleron Pharma
XLRN
| $1.36M | 0.76% |
51,296
-54,668
| -52% | -$1.44M |
|
|
YUMA
8
DELISTED
Yuma Energy Inc
YUMA
| $1.26M | 0.7% |
35,847
-1,759
| -5% | -$68.8K |
|
|
MYOK
9
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.26M | 0.7% |
95,519
+51,374
| +116% | +$658K |
|
10
Tesla
TSLA
$1.21T
| $884K | 0.49% |
47,625
| – | – |
|
|
TRVN
11
DELISTED
Trevena, Inc.
TRVN
| $858K | 0.48% |
374
-125
| -25% | -$426K |
|
|
12
Groupon
GRPN
$1.07B
| $536K | 0.3% |
+6,816
| New | +$525K |
|
|
13
Senseonics Holdings Inc
SENS
$256M
| $470K | 0.26% |
+13,129
| New | +$634K |
|
14
CytomX Therapeutics
CTMX
$701M
| $432K | 0.24% |
25,000
+15,000
| +150% | +$197K |
|
15
Twilio
TWLO
$29.5B
| $380K | 0.21% |
+13,161
| New | +$398K |
|
16
Q2 Holdings
QTWO
$3.71B
| $327K | 0.18% |
+9,381
| New | +$313K |
|
|
APTI
17
DELISTED
Apptio, Inc. Class A Common Stock
APTI
| $323K | 0.18% |
+27,551
| New | +$399K |
|
18
Atara Biotherapeutics
ATRA
$70.4M
| $217K | 0.12% |
422
| – | – |
|
19
Editas Medicine
EDIT
$402M
| – | – |
-36,362
| Closed | -$590K |
|
|
SAGE
20
DELISTED
Sage Therapeutics
SAGE
| – | – |
-23,168
| Closed | -$1.18M |
|
21
Voyager Therapeutics
VYGR
$184M
| – | – |
-36,362
| Closed | -$463K |
|
|
GBT
22
DELISTED
Global Blood Therapeutics, Inc.
GBT
| – | – |
-93,960
| Closed | -$1.36M |
|
|
SSNI
23
DELISTED
Silver Spring Networks, Inc.
SSNI
| – | – |
-10,320
| Closed | -$137K |
|
Similar funds
VCM
TCI
RPC
XC
AWA
HWM
CG
ROP
Harbourvest Partners's Q1 2017 Portfolio in Review
As of Q1 2017, Harbourvest Partners held 23 positions worth $179M, up 8% from $166M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Harbourvest Partners withdrew a net $6.7M in Q1 2017, closing 5 positions and reducing 5 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $1.36M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 81% of assets, down from 82% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Harbourvest Partners opened a new position in Kineta, Inc. Common Stock worth $3.45M.
- Harbourvest Partners's largest Q1 2017 buy was Kineta, Inc. Common Stock: 3,147 shares worth $3.45M.
- Harbourvest Partners added most to MyoKardia, Inc. Common Stock in Q1 2017, an estimated $658K increase.
- Harbourvest Partners's biggest Q1 2017 reduction was Wayfair, cutting an estimated $11.9M.
- Harbourvest Partners fully exited Global Blood Therapeutics, Inc. in Q1 2017, selling an estimated $1.36M.
- Harbourvest Partners's ten largest holdings make up 98% of its $179M portfolio in Q1 2017.
- Harbourvest Partners opened 7 new positions and closed 5 in Q1 2017.
- Harbourvest Partners's portfolio value rose 8% quarter-over-quarter to $179M.
Based on Harbourvest Partners's 13F filing for Q1 2017, filed 15 May 2017.